Ken Griffin (Citadel Advisors) add BRIDGEBIO PHARMA INC
Ken Griffin (Citadel Advisors) add $155.6M of disclosed value in BRIDGEBIO PHARMA INC.
Signal
Investor Move
Action
Add
Capital
$155.6M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.